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Abstract 
Pseudomonas aeruginosa is one of most important cause of healthcare-associated infections. 
This active surveillance cross sectional study was aimed to determine the rate of P.aeruginosa 
colonization among inpatients at three tertiary hospitals in Sana'a city. In addition, to determine risk 
factors of colonization and the antibiotic susceptibility of the isolated P.aeruginosa.  The study 
included 327 inpatients. Skin and nasopharyngeal swabs were collected from all participated patients 
and data were collected by predesigned questionnaire. Standard methods of isolation and identification 
were used to isolate bacteria in pure culture then identify. Also, antibiotic sensitivity for isolated 
P.aeruginosa was determined by the disc diffusion method. 
42 patients (12.8%) were colonized with P.aeruginosa on skin and nasopharyngeal. The 
significant risk factors of colonization were male patients (OR=2.5), older age (OR= 2.2), burn ward 
(OR=37), long stay in hospital (OR=4) and burn as underlying disease (OR=45). The isolated 
P.aeruginosa were completely resistant (100%), to Aztroneome, Ceftriaxone, and Ciprofloxacine; and 
the rates of resistant were ranged between 83.3-85.7% for Amikacin, Ampicillin sulbactam 
Levofloxacin. Also the rates were 71.4% for Netilmicin  and 92.9% for chloramphenicol. Moreover, 
the rates of resistant were low for Gentamicin (35.7%), Imipenem (11.9%), Pipracillin Tazobactam 
(11.9%), Ticaracillin calvulanic acid (31%) and Colistin sulphat (14.3%). In conclusion, this study has 
highlighted the role of hospitalization as a significant risk for P.aeruginosa colonization; concerted and 
coordinated efforts are required both in the hospital and community to tackle this.  These data 
emphasize the need to identify hospitalized patients colonized with P.aeruginosa on admission. 
Prediction rules or rapid diagnostic testing will help clinicians more appropriately choose empiric 
antibiotic therapy if subsequent infections occurred. 
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Introduction  
   Bacterial colonization in general and P.aeruginosa colonization in hospitalized patients are important 
cause of healthcare-associated infections worldwide
1
. In the United States, it is the 6th most common 
cause of healthcare-associated infections, accounting for 7.1% of all hospital infections.
2
 The choice of 
empiric antibiotics in the hospital setting is difficult. There needs to be a balance between excessively 
broad coverage and too narrow coverage. Empiric antibiotic coverage that covers P.aeruginosa but is 
broader than necessary may lead to the emergence of P.aeruginosa and other intestinal bacteria that are 
resistant to those broad spectrum antibiotics. In contrast, empiric therapy that does not cover 
P.aeruginosa may lead to poor outcomes for in-patients eventually found to have P.aeruginosa 
infection. Improvements in our understanding of which patients require broad-spectrum empiric 
coverage versus situations in which narrower spectrum agents may be appropriate would be valuable 
from an antimicrobial stewardship perspective. Knowledge of whether a patient is colonized with 
P.aeruginosa can be helpful in guiding selection of empiric antibiotics for suspected sepsis in the 
hospital setting. Colonization with P.aeruginosa is associated with subsequent infection with the same 
strain of P.aeruginosa 
3, 4
. The objectives of this active surveillance cross sectional study were as 
follows: a) Determine the prevalence of P. aeruginosa colonization on Inpatients; b) Determine risk 
factors for P. aeruginosa colonization; and c) Determine the risk factors of P. aeruginosa colonization. 
Subjects and Methods 
Site of the study  
An active surveillance cross sectional study was conducted in in-patients admitted to three tertiary 
hospitals in Sana'a city: namely: Al-Jumhori hospital, Al-Kuwait hospital and Yemen-Germen hospital, 
between January 1, 2017, and May 30, 2017.  The three hospitals are 1816-bed tertiary care facilities.  
Ethical Consideration  
Ethical clearance for the study was taken from the Faculty of Medicine and Health Sciences Research 
Review Committee. A written permission was also taken from the administrative Managers of the Al-
Jumhori hospital, Al-Kuwait hospital and Yemen-Germen hospital. Informed Consent was taken from 
the patients before the questionnaire was filled.  
Survey procedure and Laboratory Analysis  
  Skin and nasopharyngeal swabs collected from inpatients hospitalized in different wards. Clinical and 
demographic data were collected for all participants' patients. Skin and nasopharyngeal swabs were 
collected using standard collection techniques, and inoculated on appropriate bacteriological media, 
 
including blood agar and  Mac-Conkey. Then plates were incubated aerobically at 37°C for 18–24h. 
Confirmatory tests include production of the blue-green pigment pyocyanin on Cetrimide agar and 
growth at 42 °C also done. Also, the identification of isolates was made according to standard 
methods
5
. The identification was made with basic microbiological methods using colony morphology, 
Gram staining, oxidase,  Indole, catalase and coagulase tests etc 
5
. 
Antimicrobial susceptibility test  
     Antimicrobial susceptibility test for P. aeruginosa isolates were performed on Mueller-Hinton agar 
plates by the Kirby-Bauer disc diffusion method 
5
. The isolates were tested for their susceptibility against 
13 antimicrobial agents that are used in Yemen. Standardized suspension of P. aeruginosa inoculums 
was compressed to 0.5 McFarland standard turbidity, then inoculated on 3 Muller-Hinton agar plates 
using a sterile cotton swab by streaking the swab over the entire sterile agar surface 3 times. The plates 
then allowed drying and antimicrobial discs were placed at the recommended distan                    
                                             C for 24-48 hours before the zones size were record (diameter 
of inhibition zones was measured and recorded in millimeters with the help of sliding calipers, and an 
organism was labeled as sensitive or resistance as per CLSI guidelines
5
 . 
Data analysis  
   The analysis of data was done by Epi Info version 6 statistical program (CDC, Atlanta, USA), where 
the chi- q     (χ2)                 v     (p) was calculated for the test of significance. In addition, 
Odd's ratio (OR), 95% confidence interval (95% CI) were added to estimate the risk factors of skin or 
nasopharyngeal colonization P. aeruginosa on inpatients. 
Results 
The detailed results of this study are presented in 5 tables. Table 1shows the association between 
skin, nasopharyngeal P.aeruginosa colonization and sex and age of the in-patients. Table 2 
demonstrates the association between skin- nasopharyngeal P.aeruginosa colonization and type of 
wards,  table 3 illustrates the association between skin- nasopharyngeal P.aeruginosa  colonization 
and duration of hospitalization. Table 5 explains the association between skin, nasopharyngeal 
P.aeruginosa colonization and underlying diseases and table 6 shows the antibiotic sensitivity of 
isolated P.aeruginosa.  
   42 patients (12.8%) were colonized with P.aeruginosa on in skin and nasopharyngeal. The 
significant risk factors  of colonization were male patients (OR=2.5,95% CI=1.1-5.5, p=0.01), 
older age (OR= 2.2, 95% CI= 1.1–4.2, p=0.01), Burn ward (OR=37, 95% CI =16.2-84, p<0.001), 
long stay in hospital (OR=4, 95% CI =2.0-7.8, p<0.001) and burn as underlying disease (OR=45, 
95% CI =19-105, p<0.001). The isolates of  P. aeruginosa were completely resistant (100%), to 
Aztroneome, Ceftriaxone, and Ciprofloxacine and the rates of resistant were between 83.3-85.7% 
for Amikacin, Ampicillin sulbactam Levofloxacin, 71.4% for Netilmicin  and 92.9% for 
chloramphenicol. Moreover, the rates of resistant were low for Gentamicin (35.7%), Imipenem 
(11.9%), Pipracillin Tazobactam (11.9%),  Ticaracillin calvulanic acid (31%) and Colistin sulphat 
(14.3%). 
Discussion 
   In present study , there was a significant rate of skin- nasopharyngeal P.aeruginosa colonization in 
inpatients equal to 12.8% (table 1). Our result is comparable to that reported from district hospitals in 
UK 
6
.  Furthermore our study is similar to that reported previously by Parkins et al.  in which 
hospitalization was a risk factor for bacterial colonization 
7
. This association can be explained by that 
high rate of direct transmission of infectious agents in hospitals, in which this involves a direct body 
surface-to-body surface contact and physical transfer of microorganisms between a susceptible host 
and an infected or colonized person, such as when a person turns a patient, gives a patient a bath, or 
performs other patient-care activities that require direct personal contact. Direct-contact transmission 
also can occur between two patients, with one serving as the source of the infectious microorganisms 
and the other as a susceptible host
8
; or by indirect-contact transmission, which involves contact of a 
susceptible host with a contaminated intermediate object, usually inanimate, such as contaminated 
instruments, needles, or dressings, or contaminated gloves that are not changed between patients. In 
addition, the improper use of saline flush syringes, vials, and bags has been implicated in disease 
transmission in the US, even when healthcare workers had access to gloves, disposable needles, 
intravenous devices, and flushes
8
. 
 Additionally in our study, there was significant association between male patients and skin-
nasopharyngeal P.aeruginosa colonization in inpatients equal to 2.5 times with CI=1.1- 5.5 and 
PV=0.01, while no significant association was found with female. Our result is similar to that reported 
previously by several studies in which male sex was a risk factor associated with contracting bacterial 
colonization in inpatients 
1, 7-12
.  As well, there was significant association betwe          g  g     ≥50 
years and  skin-nasopharyngeal P.aeruginosa colonization in inpatients equal to 2.2 times with CI=1.1- 
 
4.2 and PV=0.01, while no significant association was found with younger age groups (table 1). This 
result is parallel to that reported previously by studies in USA and Europe in which older age group 
was a risk factor associated with contracting bacterial colonization in hospitalized patients 
1,10-12
. 
   When we considered the association between skin-nasopharyngeal P.aeruginosa  colonization and 
type of wards, there was significant associated OR equal to 37 times with CI=16.2- 84 and PV<0.0001 
with burn wards (table 2). This result is similar to that reported by Lyczak, et al. in which burn wards 
were associated risk factor with bacterial colonization in inpatients 
13
. This association can be 
explained by that original thermal injury creates a breach in the surface of the skin which make it more 
susceptible to colonization with micro-organisms, and P. aeruginosa use quorum sensing to induce the 
production of virulence factors such as proteases, hemolysins, exotoxins A and pyocyanin which help 
bacteria to colonized 
14
. However there was no significant association between ICU wards and skin-
nasopharyngeal P.aeruginosa colonization (table 2). This result is different from that reported by 
Harris et al. 
6
 in which significant association between ICU patients and colonized with P. aeruginosa 
after admission to hospitals. Our negative result might be due to our small sample size. 
As soon as we considered the association between skin-nasopharyngeal bacterial colonization and 
duration of hospitalization, there was significant associated OR equal to 4.0 times with CI=2.0- 7.8 and 
PV<0.001 wi   ≥1                   z      (       )  T                                                    
which longer period of hospitalization was a hazard factor of bacteria colonization including 
P.aeruginosa 
6,14
. This result can be explained by that contracting of bacteria by patient increase with 
longer period of exposure to micro-organisms present in hospital.  
When we considered the association between skin-nasopharyngeal P.aeruginosa colonization and type 
of underlying diseases, there was no association with  malignancy (table 4). This result is dissimilar to 
all reports in which malignancy was a risk factor for colonization bacteria in hospitalized patients 
6
.  
However, there was significant association between P.aeruginosa  colonization and burn with OR= 45, 
CI=19-105, p<0.001(table 4). This result is similar to that reported by previous reports 
8-13
 in which 
burn was risk factor of P.aeruginosa colonization 
6-13
. This association can be explained by that 
original thermal injury creates a breach in the surface of the skin which make it more susceptible to 
colonization with micro-organisms, and P. aeruginosa use quorum sensing to induce the production of 
virulence factors such as proteases, hemolysins, exotoxins A and pyocyanin which help bacteria to 
colonized as stated previously in the discussion of Burn ward
14
.  
   We carried this study because of the knowledge of P.aeruginosa prevalence and the current 
antimicrobial profile is necessary in selection of appropriate empirical treatment of these infections and 
control of P.aeruginosa  in hospitals is essential.   P.aeruginosa is a common nosocomial pathogen  
15
 
that causes infections with a high mortality rate
16  T             ,        ,                       g     ’  
intrinsically high resistance to many antimicrobials  and the development of increased, particularly 
multidrug resistance in healthcare settings  
17
, both of which complicate anti-pseudomonal 
chemotherapy. Indeed, numerous studies point to a link between multidrug resistance and increased 
morbidity/ mortality, as well as increased length of hospital stay and increased hospital costs 
18
.  In our 
study the isolated P.aeruginosa was completely resistant (100%), to Aztroneome, Ceftriaxone, and 
Ciprofloxacine. This result is different from that reported in USA in which the rate of Aztroneome, 
Ceftriaxone, and Ciprofloxacine resistant was not more than 52.2% 
19
. Also the incidence of 
Aztroneome, Ceftriaxone, and Ciprofloxacine resistant in the European countries has been documented 
by Lambert et al. 
16
 in which the rates were ranged from 50-72%. These high rates in our study can be 
 x                           q                       g     [  g ,              g β-lactamases 20 and 
aminoglycoside-modifying enzymes 
21
 via horizontal gene transfer can and do drive 
antimicrobial/multidrug resistance development in P. aeruginosa, more commonly mutations of 
chromosomal genes (target site, efflux mutations) 
22
.   The results of our study showed higher rates of 
resistant of  P. aeruginosa (83.3-85.7%) to Amikacin, Ampicillin sulbactam, and Levofloxacin. This 
result is different from study carried out at Canada  in 2010 which showed significant variable 
susceptibility pattern with lower resistance rates to Amikacin, (25%), Ampicillin sulbactam (35%), and 
Levofloxacin (25%).  There were low resistant rates of resistant for our isolated  P.aeruginosa for 
Gentamicin (35.7%), Imipenem (11.9%), Pipracillin Tazobactam (11.9%), and Ticaracillin calvulanic 
acid (31%). The current results are similar to that reported from USA  in which resistance rates to  
these antibiotics were not exciding 30%.
17
  Owing to the increased prevalence of multidrug-resistant P. 
aeruginosa, “     ”                  k            x    (      x   B             )        k      v  , 
with earlier issues surrounding nephrotoxicity largely dealt with 
23,24
. The rate in our study for Colistin 
sulphat resistant was 14.3%. This rate is similar to that reported from Russia and Western Europe. 
23,24
 
  Conclusion 
The study have been highlighted the role of hospitalization as a significant risk for P.aeruginosa 
 colonization; concerted and coordinated efforts are required both in the hospital and community to 
tackle this. Elimination of health care–associated infections is a priority of the Ministry of Health and 
 
Population.  Continued improvements in patient safety depend on maintaining a comprehensive 
understanding of the epidemiology of health care–associated infections. Currently, no single Yemen 
surveillance study can provide estimates of the burden of all types of such infections across hospital 
care patient populations. Effective antimicrobial activity as well as cost effectiveness should be 
considered in drugs prescribed for P.aeruginosa  infections. Oral dosing options  for antibiotics can 
allow earlier discharge of hospitalized patients and minimize the chances of P.aeruginosa multi-
resistant emergence. Good hospital infection control measures prove to be the main stay against these 
infections because antibiotics can never be an effective alternative to good medical practice. 
Limitation 
   This study has a number of limitations. Some data is missing and the numbers are small. Only skin 
and nasopharyngeal specimens were collected. In the protocol of the study rectal colonization was 
concerned, but most patients were refused to give rectal swab so no more than skin and nasopharyngeal 
specimens were collected. No molecular studies were used to categories samples further, in order to 
determine cross resistance or resistance mechanisms. Nevertheless, we believe this study adds further 
information to the epidemiology of a significant pathogen in the hospital setting in Sana'a city. In 
addition, although we are confident that the studied hospitals are representative of hospitals within 
Sana'a city, they may not be representative of all Yemen hospitals.   
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Table 1: The association between skin-nasopharyngeal pseudomonas aeruginosa colonization and sex 
and age of in-patients, Sana'a city, Yemen. 
 
Characters Positive P.aeruginosa 
colonization 
Negative P.aeruginosa 
colonization 
OR CI χ2 P  
No % No % 
Sex 
Male 33 16.4 168 83.6 2.5 1.1-5.5 5.9 0.01 
Female 9 7.1 117 92.9 0.39 0.18-0.8 5.9 0.01 
Age groups 
≤19       2 14.3 12 85.7 1.1 0.2-5.2 0.02 0.8 
20-29 years 4 6.3 60 93.7 0.3 0.1-1.1 3.1 0.07 
30-39 years 5 9.6 47 90.4 0.7 0.2-1.8 0.46 0.47 
40-49 years 6 10.5 51 89.5 0.7 0.3-1.8 0.27 0.6 
≥50       25 17.9 115 82.1 2.2 1.1-4.2 5.4 0.01 
Total 42 12.8 285 87.2    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: The association between skin-nasopharyngeal pseudomonas aeruginosa colonization and 
type of wards of in-patients, Sana'a city, Yemen. 
 
 
 
Wards Positive  colonization Negative  
colonization 
OR CI χ2 P  
No % No % 
ICU n= 69 9 13 60 87 1 0.41-2.5 0.003 0.95 
Burn n=48 30 62.5 18 37.5 37 16.2-84 123 <0.001 
Medical wards n=210 3 1.4 207 98.6 0.02 0.008-0.09 68 <0.001 
Total n=327 42 12.8 285 87.2    
 
 
Table 3: The association between skin-nasopharyngeal pseudomonas aeruginosa colonization and 
duration of hospitalization for in-patients, Sana'a city, Yemen. 
 
 
Duration Positive  colonization Negative  
colonization 
OR CI χ2 P  
No % No % 
1-7 days n=129 6 4.7 123 95.3 0.2 0.08-0.51 12.7 <0.001 
8-16 days n=120 15 12.5 105 87.5 0.9 0.5-1.8 0.02 0.88 
≥1        = 8 21 27 57 73 4.0 2-7.8 18.1 <0.001 
Total n= 327 42 12.8 285 86.7    
 
 
 
Table 4: The association between skin-nasopharyngeal pseudomonas aeruginosa colonization and 
underlying diseases for in-patients, Sana'a city, Yemen. 
 
Underlying disease Positive  
colonization 
Negative  
colonization 
OR CI χ2 P  
No % No % 
Burn n=45 30 66.7 15 33.3 45 19-105 135 <0.001 
Cardiovascular diseases n=66 1 1.5 65 98.5 0.08 0.01-0.6 9.4 0.002 
Malignancy n=72 8 11.1 64 88.9 0.8 0.3-1.8 0.24 0.61 
Operation n=21 1 4.8 20 95.2 0.3 0.04-2.4 1.3 0.25 
Liver diseases n=84 1 1.2 83 98.8 0.05 0.008-0.4 13.7 <0.001 
Respiratory diseases n=39 1 2.6 38 97.4 0.15 0.02-1.1 4.1 0.04 
Total n=327 42 12.8 285 87.2    
 
Table 5: Antibiotic sensitivity of isolated pseudomonas aeruginosa 
 
Antimicrobial agents Sensitive 
 
Resistance 
 
Number % Number % 
Amikacin 6 14.3 36 85.7 
Ampicillin sulbactam 7 16.7 35 83.3 
Aztroneome 0 0.0 42 100 
Ceftriaxone 0 0.0 42 100 
Chloramphenicol 3 7.1 39 92.9 
Ciprofloxacine 0 0.0 42 100 
Gentamicin 27 64.3 15 35.7 
Imipenem 37 88.1 5 11.9 
Levofloxacin 6 14.3 36 85.7 
Netilmicin 12 28.6 30 71.4 
Pipracillin Tazobactam 37 88.1 5 11.9 
Ticaracillin calvulanic acid 29 69 13 31 
Colistin sulphat 36 85.7 6 14.3 
 
